Growth Metrics

Canton Strategic Holdings (CNTN) Profit After Tax (2021 - 2026)

Canton Strategic Holdings posted quarterly Profit After Tax of -$47.3 million for Q1 2026, down 1762.66% year-on-year from $2.8 million in Q1 2025, and down 60.94% on a QoQ basis from -$29.4 million in Q4 2025.

Canton Strategic Holdings (CNTN) has 6 years of Profit After Tax data on file, last reported at -$47.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Profit After Tax fell 1762.66% year-over-year to -$47.3 million; the trailing twelve-month figure through Mar 2026 stood at -$80.7 million (down 546.61% YoY), and the FY2025 full-year result was -$35.9 million, down 194.45% from the prior year.
  • Profit After Tax for Q1 2026 stood at -$47.3 million, down from -$29.4 million in the prior quarter.
  • Across five years, Profit After Tax topped out at -$1.6 million in Q2 2022 and bottomed at -$47.3 million in Q1 2026.
  • The 5-year median for Profit After Tax is -$2.3 million (2023), against an average of -$6.7 million.
  • The widest annual swing landed in 2025, when Profit After Tax soared 44.63%; it then plunged 1762.66% in 2026.
  • A 5-year view of Profit After Tax shows it stood at -$1.8 million in 2022, then plunged by 40.04% to -$2.5 million in 2023, then slumped by 54.44% to -$3.8 million in 2024, then tumbled by 669.98% to -$29.4 million in 2025, then plunged by 60.94% to -$47.3 million in 2026.
  • The last three Profit After Tax figures came in at -$47.3 million (Q1 2026), -$29.4 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -2.99 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 30.90 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -14.46 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 1.03 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -3.63 Mn
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 727.20 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 205.99 Mn
10 Canton Strategic Holdings 643.89 Mn 602.36 Mn - -47.34 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -47.34 Mn
Dec 31, 2025 -29.42 Mn
Sep 30, 2025 -2.10 Mn
Jun 30, 2025 -1.86 Mn
Mar 31, 2025 -2.54 Mn
Dec 31, 2024 -3.82 Mn
Sep 30, 2024 -3.80 Mn
Jun 30, 2024 -2.33 Mn
Mar 31, 2024 -2.26 Mn
Dec 31, 2023 -2.47 Mn
Sep 30, 2023 -1.82 Mn
Jun 30, 2023 -2.34 Mn
Mar 31, 2023 -2.69 Mn
Dec 31, 2022 -1.77 Mn
Sep 30, 2022 -2.13 Mn
Jun 30, 2022 -1.64 Mn
Mar 31, 2022 -2.94 Mn
Dec 31, 2021 2.45 Mn
Sep 30, 2021 -853,436.00
Jun 30, 2021 -1.56 Mn
Mar 31, 2021 -2.25 Mn